Loading...
XASX
EBR
Market cap92mUSD
Aug 03, Last price  
0.27AUD
1D
-8.62%
1Q
-54.31%
IPO
-58.59%
Name

EBR Systems Inc

Chart & performance

D1W1MN
XASX:EBR chart
P/E
P/S
51.94
EPS
Div yield, %
Shrs. gr., 5y
99.64%
Rev. gr., 5y
%
Revenues
2m
1,293,935000001,617,000
Net income
-49m
L+141.68%
-24,812,7620-39,835,369-33,088,205-35,036,888-20,174,225-48,758,000
CFO
-53m
L+29.01%
000-30,355,918-32,697,514-41,229,820-53,192,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle. This innovative approach aims to address and eliminate the typical difficulties associated with traditional wired leads, such as challenging insertion, unintended nerve activation, device displacement, complex removal procedures, and the need for frequent repositioning. The company was established in 2003 and operates from its headquarters in Sunnyvale, California.
IPO date
Nov 24, 2021
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT